Neumora Therapeutics, Inc. Liquidation Value

NMRA Other

Cash & Equivalents

$182.53M
As of 2025-12-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $182.53M
Total Obligations: -$87.46M
$95.07M
Per share: $0.55
Period: 2025-12-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $182.53M
AR: $0
Total Obligations: -$87.46M
$95.07M
Per share: $0.55
Period: 2025-12-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $182.53M
AR: $0
Inventory: $0
Total Obligations: -$87.46M
$95.07M
Per share: $0.55
Period: 2025-12-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$95.07M$0.55
Liquid Liquidation Value$95.07M$0.55
Operating Liquidation Value$95.07M$0.55

Key Components (as of 2025-12-31)

Cash & Equivalents$182.53M
Accounts Receivable$1.63M
InventoryN/A
Current Liabilities$32.45M
Long-term Debt$54.53M
Op. Lease Liability$477,000
Finance LeaseN/A
Shares Outstanding174.3M

Explore all 150 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2025-12-31$182.53MN/AN/A$3.38M$32.45M$54.53M$477,000N/A
2025-09-30$129.07MN/AN/A$549,000$25.84M$19.56M$523,000N/A
2025-06-30$124.52MN/AN/A$644,000$21.16M$19.45M$510,000N/A
2025-03-31$126.86MN/AN/A$1.05M$28.38MN/A$938,000N/A
2024-12-31$142.15MN/AN/A$3.31M$29.89M$0$1.85MN/A
2024-09-30$275.71MN/AN/A$6.11M$31.74MN/A$2.75MN/A
2024-06-30$150.68M$1.63MN/A$1.08M$23.12MN/A$3.61MN/A
2024-03-31$182.93M$906,000N/A$1.49M$24.61MN/A$4.43MN/A

Comments

SEC Filings

PeriodFormFiledLink
2025-12-31 10-K 2026-03-30 View
2025-09-30 10-Q 2025-11-06 View
2025-06-30 10-Q 2025-08-06 View
2025-03-31 10-Q 2025-05-12 View
2024-12-31 10-K 2025-03-03 View
2024-09-30 10-Q 2024-11-12 View
2024-06-30 10-Q 2024-08-06 View
2024-03-31 10-Q 2024-05-07 View

Community Notes

Loading notes...

Questions

Loading questions...